Omeros (OMER) Restructuring Costs (2012)
Omeros (OMER) reported Restructuring Costs of $4.0 million for Q3 2012.
Omeros (OMER) Restructuring Costs (2012) Analysis & Trends
Omeros (OMER) has 1 years of Restructuring Costs data on file, last reported at $4.0 million in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 3.95 Mn |